Log in
Enquire now
‌

Nuevocor

Nuevocor is a developer of mechanobiology-centered therapy for cardiomyopathy founded in 2021 by Yann Chong Tan.

OverviewStructured DataIssuesContributors

Contents

nuevocor.com
Is a
Organization
Organization
Company
Company

Company attributes

Industry
Manufacturing
Manufacturing
Pharmaceutical industry
Pharmaceutical industry
Health technology
Health technology
Biotechnology
Biotechnology
CEO
‌
Yann Chong Tan
Founder
‌
Yann Chong Tan
‌
Yin Loon Lee
Number of Employees (Ranges)
11 – 50
Email Address
info@nuevocor.com
Investors
Kurma Partners
Kurma Partners
Boehringer Ingelheim Venture Fund
Boehringer Ingelheim Venture Fund
Seeds Capital
Seeds Capital
Highlight Capital
Highlight Capital
EDBI
EDBI
‌
Angelini Ventures
‌
ClavystBio
Founded Date
2021
Total Funding Amount (USD)
69,000,000
Latest Funding Round Date
May 5, 2025
Latest Funding Type
Series B
Series B
Country
United States
United States
Singapore
Singapore
Headquarters
Washington (state)
Washington (state)

Other attributes

Latest Funding Round Amount (USD)
45,000,000
No article content yet.

Timeline

No Timeline data yet.

Funding Rounds

Products

Acquisitions

SBIR/STTR Awards

Patents

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more companies like Nuevocor

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.